Memorial Sloan Kettering is pursuing a variety of initiatives aimed at making sure everyone who walks through our doors feels welcome.
IBM’s Watson won Jeopardy!, but what if its power could be used for the greater good to help make better cancer care choices?
Increasingly, women diagnosed with cancer in one breast are choosing to have their other, healthy breast removed, but experts say this additional surgery provides no survival benefits.
Memorial Sloan Kettering social worker Carrie Panzer offers tips for coping with hair loss.
Researchers have identified a genetic mutation that appears to cause a rare but very aggressive type of ovarian cancer in young women.
Watch a video of an annual event that gives voice to writings composed by Memorial Sloan Kettering patients.
A study has found that mutations in the gene BRCA1 are associated with an increased likelihood of developing a rare, aggressive form of uterine cancer.
Cancer genetics experts say the discovery of the BRCA gene mutations has transformed the way doctors prevent and treat hereditary cancers.
In this Ask the Expert feature, colorectal surgeon Julio Garcia-Aguilar discusses the differences between laparoscopy and robotic surgery and explains which patients are the best candidates for these procedures.
Cancer treatments, both traditional treatments and newer targeted therapies, can lead to short-term and long-term heart problems.